Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Br J Nutr ; 105(6): 895-901, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21114893

RESUMEN

Several epidemiological studies have related an increase of lipids in the postprandial state to an individual risk for the development of CVD, possibly due to the increased plasma levels of TAG and fatty acids (FA) through enzymes of FA metabolism. The interaction between nutrition and the human genome determines gene expression and metabolic response. The aim of the present study was to evaluate the influence of a fat overload on the gene mRNA levels of lipogenic regulators in peripheral blood mononuclear cells (PBMC) from patients with the metabolic syndrome. The study included twenty-one patients with criteria for the metabolic syndrome who underwent a fat overload. Measurements were made before and after the fat overload of anthropometric and biochemical variables and also the gene mRNA levels of lipogenic factors. The main results were that the fat overload led to an increased mRNA levels of sterol regulatory element binding protein-1 (SREBP1), retinoid X receptor α (RXRα) and liver X receptor α (LXRα) in PBMC, and this increase was associated with the FA synthase (FASN) mRNA levels. We also found that TAG levels correlated with FASN mRNA levels. In addition, there was a positive correlation of SREBP1 with RXRα and of LXRα with the plasma lipoperoxide concentration. The fat overload led to an increase in regulators of lipogenesis in PBMC from patients with the metabolic syndrome.


Asunto(s)
Grasas de la Dieta/farmacología , Ácido Graso Sintasas/metabolismo , Lipogénesis/efectos de los fármacos , Síndrome Metabólico/metabolismo , Receptores Nucleares Huérfanos/biosíntesis , Receptores X Retinoide/biosíntesis , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/metabolismo , Grasas de la Dieta/administración & dosificación , Ácido Graso Sintasas/genética , Femenino , Humanos , Leucocitos Mononucleares/efectos de los fármacos , Peróxidos Lipídicos/sangre , Lipogénesis/genética , Lipogénesis/fisiología , Receptores X del Hígado , Masculino , Síndrome Metabólico/genética , ARN Mensajero/biosíntesis , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/genética , Triglicéridos/sangre
2.
Anticancer Res ; 26(2A): 1011-4, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16619500

RESUMEN

BACKGROUND: In previous reports, changes in oxytocinase activity in human breast cancer tissue and in the serum of N-methyl-nitrosourea (NMU)-induced rat mammary tumors were described. Insulin-regulated aminopeptidase (IRAP) has been identified with oxytocinase and has also been referred to as placental leucine aminopeptidase (P-LAP). MATERIALS AND METHODS: The IRAP/P-LAP activity in rat serum was assayed to analyze the putative role that IRAP/P-LAP may play in regulating mammary gland carcinogenesis induced by NMU. Furthermore, as it has been recently described that IRAP/P-LAP is the angiotensin IV (Ang IV) receptor AT4, the activities of Ang IV-forming aminopeptidase N (APN) and aminopeptidase B (APB) were also assayed. RESULTS: Changes in serum IRAP/P-LAP and Ang IV-forming APB activities were found in rats with mammary tumors induced by NMU. Both activities were greatly increased, although the Ang IV-forming APN activity was not modified. CONCLUSION: These changes in aminopeptidase activities may reflect the local functional status of their substrates, which can be selectively activated or inhibited in the affected tissue as a result of specific conditions brought about by the tumor. Thus, these enzymatic activities may be involved in the promotion and progression of breast cancer through oxytocin (OT), vasopressin (AVP) and/or renin-angiotensin system (RAS) misregulation.


Asunto(s)
Aminopeptidasas/sangre , Angiotensina II/análogos & derivados , Cistinil Aminopeptidasa/sangre , Neoplasias Mamarias Experimentales/enzimología , Angiotensina II/biosíntesis , Angiotensina II/sangre , Animales , Femenino , Neoplasias Mamarias Experimentales/sangre , Neoplasias Mamarias Experimentales/inducido químicamente , Metilnitrosourea , Ratas , Ratas Wistar , Receptores de Angiotensina/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA